Kentucky SB283 prohibits Medicaid funds from covering hormones for gender dysphoria and gender reassignment surgery.
Kentucky SB283 amends the state's Medicaid provisions to prohibit the Department for Medicaid Services and any managed care organizations from using Medicaid funds for cross-sex hormones when prescribed for gender dysphoria or for gender reassignment surgery. This change aims to restrict coverage for treatments related to gender transition under the state's Medicaid program.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.